ArticleOncoTargets and therapy2021

Icotinib versus Cisplatin Plus Docetaxel as Adjuvant Chemotherapy in Patients with Stage II (N1+) Non-Small Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.

Saibo Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.